Cue Biopharma CUE
NASDAQ CUE
$18.42 -0.47 (-2.49%)
As of: Oct 23, 2026 · 1:28 PM EDT

Cue Biopharma (CUE) Short-term Investments (2018 - 2025)

Updated

Cue Biopharma (CUE) recorded Short-term Investments of $7 million in Q3 2025.

Analysis

Cue Biopharma (CUE) Short-term Investments (2018 - 2025) Analysis & Trends

At the end of FY2022, Cue Biopharma reported Short-term Investments of $24.68 million.

  • Annual Short-term Investments has a four-year compound annual growth rate of 7.6% (FY2018 to FY2022).
  • Across earlier years, Short-term Investments came in at $10 million in FY2020 (-33.8%), $15.12 million in FY2019 (-17.9%) and $18.41 million in FY2018.
  • The Q3 2025 figure is the highest quarterly Short-term Investments since Q1 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,138.00 Bn 1,106.58 Bn 19.71 Bn
2 Johnson & Johnson 634.40 Bn 554.26 Bn 17.30 Bn
3 AbbVie 506.36 Bn 479.47 Bn 12.70 Bn
4 Merck 358.30 Bn 312.68 Bn 12.21 Bn
5 Novartis Ag 293.12 Bn 257.11 Bn 11.24 Bn
6 Astrazeneca 265.36 Bn 239.05 Bn 12.86 Bn
7 Amgen 238.40 Bn 193.80 Bn 7.24 Bn
8 Gilead Sciences 195.15 Bn 169.35 Bn 6.22 Bn
9 Pfizer 170.83 Bn 117.47 Bn 10.94 Bn
10 Cue Biopharma 116.80 Mn 26.07 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 7.00 Mn
Jun 30, 2023 4.99 Mn
Mar 31, 2023 9.88 Mn
Dec 31, 2022 24.68 Mn
Sep 30, 2022 29.46 Mn
Dec 31, 2020 10.00 Mn
Sep 30, 2020 20.07 Mn
Mar 31, 2020 25.30 Mn
Dec 31, 2019 15.12 Mn
Jun 30, 2019 4.00 Mn
Mar 31, 2019 8.97 Mn
Dec 31, 2018 18.41 Mn
Sep 30, 2018 23.34 Mn
Mar 31, 2018 50,000.00
API Access

Cue Biopharma Short-term Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-investments&ticker=CUE&period=max&api_key=YOUR_API_KEY